Literature DB >> 21963520

Yes! Statins can be given to liver patients.

Ted Bader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21963520     DOI： 10.1016/j.jhep.2011.08.016

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  13 in total

1.  Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink.

Authors:  Katherine A McGlynn; Katrina Hagberg; Jie Chen; Barry I Graubard; W Thomas London; Susan Jick; Vikrant V Sahasrabuddhe
Journal:  J Natl Cancer Inst       Date:  2015-02-26       Impact factor: 13.506

Review 2.  Clinical perspective: statins and the liver--harmful or helpful?

Authors:  James H Lewis
Journal:  Dig Dis Sci       Date:  2012-05-12       Impact factor: 3.199

Review 3.  Statin therapy in patients with cirrhosis.

Authors:  Andrew P Wright; Srinath Adusumalli; Kathleen E Corey
Journal:  Frontline Gastroenterol       Date:  2014-08-08

4.  Statin use and risk of hepatocellular carcinoma in a U.S. population.

Authors:  Katherine A McGlynn; George W Divine; Vikrant V Sahasrabuddhe; Lawrence S Engel; Ashley VanSlooten; Karen Wells; Marianne Ulcickas Yood; Sharon Hensley Alford
Journal:  Cancer Epidemiol       Date:  2014-08-10       Impact factor: 2.984

Review 5.  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Niki Katsiki; Michael Doumas; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

6.  Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected Outpatients.

Authors:  Matthew E Levy; Alan E Greenberg; Manya Magnus; Naji Younes; Amanda Castel
Journal:  AIDS Patient Care STDS       Date:  2018-02       Impact factor: 5.078

7.  Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.

Authors:  Konstantinos Kargiotis; Vasilios G Athyros; Olga Giouleme; Niki Katsiki; Evangelia Katsiki; Panagiotis Anagnostis; Chrysoula Boutari; Michael Doumas; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

8.  Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.

Authors:  Nora T Oliver; Christine M Hartman; Jennifer R Kramer; Elizabeth Y Chiao
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

Review 9.  Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies.

Authors:  Rolf Teschke; Gaby Danan
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

10.  Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study.

Authors:  Helmi M'Kada; Hugo Perazzo; Mona Munteanu; Yen Ngo; Nittia Ramanujam; Bruno Fautrel; Françoise Imbert-Bismut; Vlad Ratziu; Ina Schuppe-Koistinen; Véronique Leblond; Jean Yves Delattre; Yves Samson; Olivier Lyon Caen; François Bricaire; David Khayat; Charles Pierrot-Deseilligny; Serge Herson; Zahir Amoura; Patrick Tilleul; Olivier Deckmyn; Pierre Coriat; Vincent Nicolas Delpech; Philippe Boulogne; Dominique Bonnefont-Rousselot; Thierry Poynard
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.